Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03861806 · ClinicalTrials.gov registry record · NA

Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke

A NA study, sponsored by Burke Medical Research Institute.

Terminated
Registry status
NA
Development phase
15
Enrollment target

NCT03861806: Clinical Trial NA study, sponsored by Burke Medical Research Institute.

NCT03861806 is a NA study that was terminated before completion, run by Burke Medical Research Institute. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03861806, a NA study, was terminated before completion, sponsored by Burke Medical Research Institute.

TERMINATED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

Paired associative stimulation (PAS) is a non-invasive stimulation method which is known to modulate corticospinal excitability through mechanisms related to long-term potentiation and long-term depression. The purpose of this study is to determine the reliability of individual subject's response (i.e., change in corticospinal excitability) to PAS in patients with chronic stroke (\>6 months) with upper limb motor deficits.

Primary Outcome

Assessment of corticospinal excitability

Interventions

  • BEHAVIORAL PAS true
  • BEHAVIORAL PAS sham

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2019-04-17
Est. Completion 2022-09-12
Phase NA
Burke Medical Research Institute

11 total trials

Why NCT03861806 stopped before completion

NCT03861806 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which PAS true is the first listed.

NCT03861806 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03861806 about?

NCT03861806 is a clinical study titled "Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke". Paired associative stimulation (PAS) is a non-invasive stimulation method which is known to modulate corticospinal excitability through mechanisms related to long-term potentiation and long-term depression. The purpose of this study is to determine the reliability of individual subject's response (i...

What is the current status of trial NCT03861806?

This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2019-04-17. Estimated completion is 2022-09-12.

What interventions are being tested in trial NCT03861806?

The interventions under investigation include: PAS true (BEHAVIORAL), PAS sham (BEHAVIORAL).

Who is sponsoring clinical trial NCT03861806?

This trial is sponsored by Burke Medical Research Institute, which has 11 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03861806's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03861806, the US trial registry maintained by the National Library of Medicine. NCT03861806 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.